GEG
Great Elm Group, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$2.22
+0.91%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 27.8M | 27.8M | 16.3M | 17.8M | 8.7M |
| Cost of Revenue | 28.7M | 34.1M | 16.4M | 16.9M | 10.2M |
| Gross Profit | (935.0K) | (6.4M) | (108.0K) | 977.0K | (1.5M) |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 11.6M | 7.4M | 6.6M | 7.7M | 8.5M |
| General & Admin Expense | 5.8M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 1.5M | 224.0K | 1.3M | 1.2M | 1.2M |
| Total Operating Expenses | 13.1M | 7.7M | 7.9M | 8.8M | 9.7M |
| Cost and Expenses | 41.8M | 41.8M | 24.3M | 25.7M | 19.9M |
| Operating Income (EBIT) | (14.0M) | (14.0M) | (8.0M) | (7.8M) | (11.2M) |
| Non-Operating | |||||
| Interest Income | 2.1M | 1.7M | 1.6M | 829.0K | — |
| Interest Expense | 4.1M | 4.1M | 4.2M | 4.3M | 6.1M |
| Net Interest Income | (2.0M) | (2.4M) | (2.6M) | (3.5M) | (6.1M) |
| Other Non-Op Income/Expense | (23.3M) | (23.3M) | 23.6M | 7.0M | 25.9M |
| Non-Operating Income (excl Interest) | 19.2M | — | (27.8M) | (11.3M) | (32.0M) |
| EBT (Pre-Tax Income) | (37.3M) | (37.3M) | 15.6M | (841.0K) | 14.7M |
| Income Tax Expense | (376.0K) | (376.0K) | 86.0K | 101.0K | 200.0K |
| Bottom Line | |||||
| Net Income | (35.4M) | (35.4M) | 12.9M | (1.4M) | 27.7M |
| Earnings from Cont. Ops | (36.9M) | (36.9M) | 15.6M | (942.0K) | 14.5M |
| Earnings from Discont. Ops | — | — | — | 16.0K | (1.6M) |
| Bottom Line Net Income | (35.4M) | (35.4M) | 14.8M | (1.4M) | 16.0M |
| Per Share | |||||
| Basic EPS | ($1.15) | ($1.17) | $0.47 | ($0.05) | $0.50 |
| Diluted EPS | ($1.15) | ($1.17) | $0.33 | ($0.05) | $0.40 |
| Revenue Per Share | $0.92 | $0.92 | $0.59 | $0.60 | $0.30 |
| Shares | |||||
| Basic Shares Outstanding | 30.3M | 30.3M | 27.6M | 30.0M | 28.9M |
| Diluted Shares Outstanding | 30.3M | 30.3M | 38.8M | 30.0M | 41.0M |
| Profitability Metrics | |||||
| EBITDA | (31.9M) | (12.7M) | 21.0M | 4.6M | 21.9M |
| D&A | 1.3M | 1.3M | 1.2M | 1.1M | 1.2M |
| EBIT | (33.2M) | (14.0M) | 19.8M | 3.5M | 20.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026